Press Releases

Date Title
6/2/22 Sarepta Therapeutics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference
5/31/22 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
5/5/22 Sarepta Therapeutics Launches Inaugural LGMD Grant Award Program
5/5/22 Sarepta Therapeutics lanza el programa inaugural de concesión de subvenciones para la LGMD
5/4/22 Sarepta Therapeutics Announces First Quarter 2022 Financial Results and Recent Corporate Developments
5/4/22 Sarepta Therapeutics to Present at the BofA Securities 2022 Healthcare Conference
4/29/22 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4/27/22 Sarepta Therapeutics to Announce First Quarter 2022 Financial Results and Recent Corporate Developments on May 4, 2022
3/31/22 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/8/22 Sarepta Therapeutics Announces Fifth Year of Route 79, The Duchenne Scholarship Program
Displaying 61 - 70 of 788